[HTML][HTML] Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies

K Dhama, F Nainu, A Frediansyah, MI Yatoo… - Journal of infection and …, 2023 - Elsevier
Newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are continuously posing high global public health concerns and panic resulting in waves of …

Carbon dots in bioimaging, biosensing and therapeutics: a comprehensive review

B Wang, H Cai, GIN Waterhouse, X Qu, B Yang… - Small …, 2022 - Wiley Online Library
Carbon dots (CDs), comprising crystalline graphitized carbon cores and polymer surface
groups, are currently attracting a lot of interest in biological fields owing to their fluorescent …

[HTML][HTML] Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

OJ Watson, G Barnsley, J Toor, AB Hogan… - The Lancet infectious …, 2022 - thelancet.com
Background The first COVID-19 vaccine outside a clinical trial setting was administered on
Dec 8, 2020. To ensure global vaccine equity, vaccine targets were set by the COVID-19 …

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

PB Gilbert, DC Montefiori, AB McDermott, Y Fong… - Science, 2022 - science.org
In the coronavirus efficacy (COVE) phase 3 clinical trial, vaccine recipients were assessed
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …

Emergence of SARS-CoV-2 Omicron (B. 1.1. 529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic

R Khandia, S Singhal, T Alqahtani, MA Kamal… - Environmental …, 2022 - Elsevier
Since the appearance in the late of December 2019, SARS-CoV-2 is rapidly evolving and
mutating continuously, giving rise to various variants with variable degrees of infectivity and …

Understanding COVID-19 vaccine hesitancy

S Machingaidze, CS Wiysonge - Nature medicine, 2021 - nature.com
Understanding COVID-19 vaccine hesitancy | Nature Medicine Skip to main content Thank you
for visiting nature.com. You are using a browser version with limited support for CSS. To obtain …

Efficacy and safety of a recombinant plant-based adjuvanted Covid-19 vaccine

KJ Hager, G Pérez Marc, P Gobeil… - New England journal …, 2022 - Mass Medical Soc
Abstract Background Coronavirus-like particles (CoVLP) that are produced in plants and
display the prefusion spike glycoprotein of the original strain of severe acute respiratory …

COVID-19 vaccine hesitancy—A scoping review of literature in high-income countries

J Aw, JJB Seng, SSY Seah, LL Low - Vaccines, 2021 - mdpi.com
Vaccine hesitancy forms a critical barrier to the uptake of COVID-19 vaccine in high-income
countries or regions. This review aims to summarize rates of COVID-19 hesitancy and its …

COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries

JS Solís Arce, SS Warren, NF Meriggi, A Scacco… - Nature medicine, 2021 - nature.com
Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient
immunization coverage to end the global pandemic, yet few studies have investigated …

[HTML][HTML] Evidence for antibody as a protective correlate for COVID-19 vaccines

KA Earle, DM Ambrosino, A Fiore-Gartland, D Goldblatt… - Vaccine, 2021 - Elsevier
A correlate of protection (CoP) is urgently needed to expedite development of additional
COVID-19 vaccines to meet unprecedented global demand. To assess whether antibody …